Amalgamated Financial’s Usana Health Sciences USNA Stock Holding History

Amalgamated Financial’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$457K	Buy	+5,748	New	+$518K	﹤0.01%	1555

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Amalgamated Financial's USNA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Usana Health Sciences (USNA) in Q1 2022: 5,748 shares worth $457K. The stake represents ﹤0.01% of the portfolio and ranks #1555 among its holdings.

179 funds tracked by Wall St. Rank hold USNA as of Q1 2022.

Amalgamated Financial held 5,748 shares of Usana Health Sciences worth $457K as of Q1 2022.
Usana Health Sciences was a new Amalgamated Financial position in Q1 2022.
Usana Health Sciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1555 holding.
179 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.